samedan logo
 
 
spacer
home > pmps > Winter 2020
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Winter 2020

   
Text
PDF
bullet
Feature topics
Serious Challenges, Great Opportunities

Teemu Patala at Airport College
 
New staff training methods should be considered to achieve excellence in supply chain logistics.
 
view
download pdf
bullet
Extractables and Leachables
An Exercise in Quality Risk Management

Jason Creasey at Maven E&L

‘Extractables’ and ‘leachables’ are mutually exclusive terms, and have a specific value to quality risk management.
 
view
download pdf
Advancing the Detection of E&L by Pharma Manufacturers

Xiaoteng Gong and Dr Dujuan Lu at SGS and Daniela Cavagnino at Thermo Fisher Scientific

Coupling headspace chromatography with mass spectrometry can help assess and quantify volatile extractables in pharma workflows.
 
view
download pdf
Transdermal Delivery Systems

Dr Wayland Rushing at Eurofins

Many problems arise from the increased popularity of transdermal delivery systems, but new FDA guidance may help offset these.
 
view
download pdf
The Landscape for Single-Use Systems

Jessica Shea at Merck 

Single-use systems hold great potential to reduce costs, start-up times, and improve E&L risk evaluation.
 
view
download pdf
Application of Simulation Studies to E&L Programmes

Michael Creese at Smithers

Simulation studies can help scientists in E&L testing ensure the most sterile products and reduce toxicity.
 
view
download pdf
Practical Considerations

Alan Wood at RSSL

Thorough knowledge and planning are required to ensure the E&L study can accommodate a wide range of formulations.
 
view
download pdf
bullet
Green Supply Chain
The Economy or the Environment?

Jason Hibbs at Jet Environmental

The pharma industry should start acting to address the needs of a future-proof sustainable supply chain.
 
view
download pdf
Sustainable Supply Chains

Greg Wheatley at Peli BioThermal

The packaging industry is steadily improving the balance between effective pharmaceutical protection and minimal environmental impact.
 
view
download pdf
Striving to Ship Environmentally Friendly

Aat van der Meer at Dachser Benelux

Third-party service providers may be the solution to an environmentally friendly future.
 
view
download pdf
Making Use of the Reusable

Florence Lehec at EMBALL’ISO Group

Reusable insulated packaging should take the place of single use approaches to ensure minimal damage to the environment.
 
view
download pdf
bullet
Packaging Innovations
A Rapidly Changing Landscape

Tom McClean at West Pharmaceutical Services, Inc

In an ever-evolving market, all pharma healthcare players must learn to innovate swiftly or face being lost by the wayside.
 
view
download pdf
Pharmapack Foreword

Discover the latest developments and packaging solutions, with an exclusive introduction from Pharmapack.
 
view
download pdf
A New Era for Packaging Technologies

Andrew Smith at Rockwell Automation

Despite the technology becoming ever more advanced, it is best to keep packaging lines simple.
 
view
download pdf
Spotlight: How Can Nasal Drug Delivery Devices Increase Patient Compliance and Safety?

Nemera showcase its Advancia®, the nasal spray designed to help improve patient adherence and health.

 
view
download pdf
Smart Packaging: Increasing Therapeutic Adherence

Chris Waterhouse at iDi Pac

Failure to adhere to medication treatment is often a result of forgetfulness, but smart packaging and technology may be a solution.
 
view
download pdf
Thermoforming: The Ideal Product Packaging Solution?

Alastair Cook at ULMA Packaging UK

Thermoforming processes may be the answer as the pharma industry seeks to mitigate costs and waste.
 
view
download pdf
bullet
Inhalation Technology Supplement
Smart Inhalers: The Value and the Challenge

Iain Simpson at Phillips-Medisize

Improved outcomes to patient adherence is a necessity in a world where asthma cases are rising globally. Perhaps smart inhalers hold the solution.
 
view
download pdf
Counteracting the Effects of an Opioid Overdose

Todd D Pizitz and Donald R Mealing at CounterAct

Have we found the way to ameliorate the opioid epidemic that is currently taking hold in the US?
 
view
download pdf
A New Era for Mesh Nebulisers

Hernan Cuevas Brun at HCmed Innovations

Is a renaissance in mesh nebuliser technology upon us? Old methods are being revitalised in new ways to treat respiratory diseases.
 
view
download pdf
Spotlight: Dose Counters and Indicators – A Real Patient Need

H&T Presspart showcases its fully embedded and connected metered-dose inhaler eMDITM, which aims to improve patient adherence.
 
view
download pdf
A Combination of Problems

Lei Mao at Recipharm Laboratories 

Products combining multiple active pharmaceutical ingredients may lead to more effective treatments for patients; however, they are much more complex to create.
 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Synthetic Cannabinoid Compounds for Treating Neuroinflammatory and Neurodegenerative Diseases

MyMD Pharmaceuticals Inc., a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,085,047 titled “Synthetic Cannabinoid Compounds for the Treatment of Substance Addiction and Other Disorders.”
More info >>

White Papers

Maximize the ROI of Your Post-Approval Research

Bioclinica

Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources you’ve committed to post-approval research, you may be wondering if you’re getting the greatest possible return on your investment. Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement